EMA:
EMA - BEGINS PHASED REVIEW OF DARAXONRASIB FOR METASTATIC PANCREATIC CANCER
EMA: FAST TRACKS REVIEW OF DARAXONRASIB FOR METASTATIC PANCREATIC CANCER
Reuters
EMA Fast Tracks Review Of Medicine For Metastatic Pancreatic Cancer
- Sources
- Reuters
- Markets
- Stocks
- Active symbols
- NASDAQ:RVMD
- Language
- English (India)
EMA: